Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Receptor–receptor interactions within receptor heterodimers and receptor mosaics formed by different types of GPCRs represent an important integrative mechanism for signaling in brain networks at the level of the plasma membrane. The malfunction of special heterodimers and receptor mosaics in the ventral striatum containing D2 receptors and 5-HT2A receptors in cortical networks may contribute to disturbances of key pathways involving ventral striato-pallidal GABA neurons and mediodorsal thalamic prefrontal glutamate neurons that may lead to the development of schizophrenia. The ventral striatum transmits emotional information to the cerebral cortex through a D2 regulated accumbal–ventral pallidal–mediodorsal–prefrontal circuit which is of special interest to schizophrenia in view of the reduced number of glutamate mediodorsal–prefrontal projections associated with this disease. This circuit is especially vulnerable to D2 receptor activity in the nucleus accumbens, since it produces a reduction in the prefrontal glutamate drive from the mediodorsal nucleus. The following D2 receptor containing heterodimers/receptor mosaics are of special interest to schizophrenia: A2A–D2, mGluR5–D2, CB1–D2, NTS1–D2 and D2–D3 and are discussed in this review. They may have a differential distribution pattern in the local circuits of the ventral striato-pallidal GABA pathway, predominantly located extrasynaptically. Specifically, trimeric receptor mosaics consisting of A2A–D2–mGluR5 and CB1–D2–A2A may also exist in these local circuits and are discussed. The integration of receptor signaling within assembled heterodimers/receptor mosaics is brought about by agonists and allosteric modulators. These cause the intramembrane receptor–receptor interactions, via allosteric mechanisms, to produce conformational changes that pass over the receptor interfaces. Exogenous and endogenous cooperativity is discussed as well as the role of the cortical mGluR2–5-HT2A heterodimer/receptor mosaic in schizophrenia (Gonzalez-Maeso et al. 2008). Receptor–receptor interactions within receptor heterodimer/receptor mosaics of different receptors in the ventral striatum and cerebral cortex give novel strategies for treatment of schizophrenia involving, e.g., monotherapy with either A2A, mGluR5, CB1 or NTS1 agonists or combined therapies with some of these agonists combined with D2-like antagonists that specifically target the ventral striatum. In addition, a combined targeting of receptor mosaics in the ventral striatum and in the cerebral cortex should also be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)62678-3 · Cited by 1,961
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · cited 4×
“Evidence for this includes a marked increase in extracellular levels of anandamide following D2 agonist administration as well as D2 regulation of 2-arachidonoyl-glycerol (2-AG) signaling (Giuffrida et al. 1999; Piomelli 2003; Uchigashima et al. 2007).”
InfluentialHaber, S. N., Fudge, J. L., & McFarland, N. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02369.2000 · Cited by 1,610 · cited 2×
“arise from the nucleus accumbens shell to the dorsolateral striatum (Haber et al. 2000).”
Surmeier, D. J., Ding, J., Day, M., Wang, Z., & Shen, W. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.008 · Cited by 1,203 · cited 1×
“(AMPA) and voltage-dependent sodium channels (Nav), favoring the silencing of the D2 striatopallidal neurons (Surmeier et al. 2007).”
Dichotomous dopaminergic control of striatal synaptic plasticity
Shen, W., Flajolet, M., Greengard, P., & Surmeier, D. J. (2008) · Science · doi:10.1126/science.1160575 · Cited by 1,190 · cited 17×
“In fact, in D2 containing striato-pallidal nerve cells, timing-dependent LTD is not able to develop after the blockade of CB1 receptors on the glutamate terminals, demonstrating that these receptors are required for the reduction of glutamate release (Shen et al. 2008).”
InfluentialPatil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., et al. (2007) · Nature Medicine · doi:10.1038/nm1632 · Cited by 1,040 · cited 2×
“Furthermore, a randomized phase II clinical trial in schizophrenia using a mGluR2/3 agonist indicates their therapeutic potential in this disease (Patil et al. 2007).”
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · cited 2×
“Psilocybine induces schizophrenia-like psychosis in humans through the activation of 5-HT2A receptors (Vollenweider et al. 1998).”
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988 · cited 1×
“Certain antipsychotic drugs, such as risperidone, have now been identified by their high affinity for the 5-HT2A receptor that results in a blockade of 5-HT2A activity (Lieberman et al. 1998, Colpaert 2003, Miyamoto et al. 2005).”
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925 · cited 2×
“Evidence indicates that hallucinogens act by recruiting specific cortical 5-HT2A receptor-mediated signaling pathways (Gonzalez-Maeso et al. 2007), which non-hallu- cinogenic 5-HT2A agonists cannot activate.”
Identification of a serotonin/glutamate receptor complex implicated in psychosis
González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., et al. (2008) · Nature · doi:10.1038/nature06612 · Cited by 803 · cited 14×
“This will reduce the hallucinogenic-specific Gi/o signaling and behavior over the 5-HT2A receptor with a reduction of primary disturbances in cortical sensory processing (Gonzalez-Maeso et al. 2008).”
InfluentialEndocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
Kreitzer, A. C., & Malenka, R. C. (2007) · Nature · doi:10.1038/nature05506 · Cited by 735 · cited 1×
“…line with this hypothesis, it has been reported that in schizophrenic patients the ananda- mide cerebrospinal fluid (CSF) levels are inversely correlated to psychotic symptoms, probably due to the activation of the CB1 receptors in the mentioned D2 containing receptor mosaics (Leweke et al. 2007).”
Belin, D., & Everitt, B. J. (2008) · Neuron · doi:10.1016/j.neuron.2007.12.019 · Cited by 697 · cited 2×
“rely on DA-dependent serial connectivity from the ventral striatum to the dorsal striatum for their development (Belin and Everitt 2008).”
D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617 · cited 2×
“The CB1 agonist delta-9-tetrahydrocannabinol (D9-THC) may exacerbate psychotic symptoms in schizophrenia (D’Souza et al. 2005) because of a high affinity for CB1 homodimers/ receptor mosaics.”
Sturm, V., Lenartz, D., Koulousakis, A., Treuer, H., Herholz, K., Klein, J. C., & Klosterkötter, J. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.09.003 · Cited by 567 · cited 2×
“also exist in schizophrenia where obsessive-compulsive symptoms may develop (Sturm et al. 2003; van Kuyck et al. 2007).”
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529 · cited 2×
“In fact, metabotropic glutamate 2/3 receptors have been regarded as targets for antischizophrenic drugs (Aghajanian and Marek 2000; Marek 2004).”
Groenewegen, H. J., Berendse, H. W., & Haber, S. N. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90115-v · Cited by 456 · cited 2×
“The ventral pallidum connects to the subthalamic nucleus becoming part of the indirect pathway from the dorsal striatum (Groenewegen et al. 1993).”
Hernández-López, S., Tkatch, T., Perez-Garci, E., Galarraga, E., Bargas, J., Hamm, H., & Surmeier, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-08987.2000 · Cited by 443 · cited 1×
“…voltage- dependent calcium channels, dopamine and cyclic AMP- regulated phosphoprotein with molecular weight 32 kDa (DARPP-32) at threonine 34 and of GluR1–AMPA receptors playing an important role in synaptic plasticity (Hernandez-Lopez et al. 2000, Hakansson et al. 2006, Bateup et al. 2008).”
Lysergic acid diethylamide: Sensitive neuronal units in the midbrain raphe
Aghajanian, G. K., Foote, W. E., & Sheard, M. H. (1968) · Science · doi:10.1126/science.161.3842.706 · Cited by 404 · cited 2×
“Instead, Aghajanian et al. (1968) proposed that the hallucinogenic effects of d-LSD was produced by the activation of a presynaptic 5-HT receptor on the raphe nerve cells.”
González-Maeso, J., Yuen, T., Ebersole, B. J., Wurmbach, E., Lira, A., Zhou, M., Weisstaub, N., Hen, R., Gingrich, J. A., & Sealfon, S. C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08836.2003 · Cited by 297 · cited 2×
“This can also explain the observations that you can distinguish between hallucinogenic and non-hallucinogenic 5-HT2A agonists by transcriptome fingerprints (Gonzalez-Maeso et al. 2003).”
Prominence of the dopamine D2 short isoform in dopaminergic pathways
Khan, Z. U., Mrzljak, L., Gutierrez, A., de la Calle, A., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7731 · Cited by 278 · cited 2×
“The D2-long isoform of the D2 receptor is mainly located in the dendrites of the striato-pallidal GABA neu- rons, while the D2-short isoform represents the D2 autoreceptor on DA terminals inhibiting DA release (Khan et al. 1998).”
Cell type–specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs
Bateup, H. S., Svenningsson, P., Kuroiwa, M., Gong, S., Nishi, A., Heintz, N., & Greengard, P. (2008) · Nature Neuroscience · doi:10.1038/nn.2153 · Cited by 233 · cited 1×
“…voltage- dependent calcium channels, dopamine and cyclic AMP- regulated phosphoprotein with molecular weight 32 kDa (DARPP-32) at threonine 34 and of GluR1–AMPA receptors playing an important role in synaptic plasticity (Hernandez-Lopez et al. 2000, Hakansson et al. 2006, Bateup et al. 2008).”
Cannabidiol monotherapy for treatment-resistant schizophrenia
Zuardi, A. W., Hallak, J. E. C., Dursun, S. M., Morais, S. L., Sanches, R. F., Musty, R. E., & Crippa, J. A. S. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106060967 · Cited by 192
Cited by
The discovery of central monoamine neurons gave volume transmission to the wired brain
Fuxe, K., Dahlström, A. B., Jonsson, G., Marcellino, D., Guescini, M., Dam, M., Manger, P., & Agnati, L. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.012 · Cited by 285
Self-citationThe G protein-coupled receptor heterodimer network (GPCR-HetNet) and its hub components
Borroto-Escuela, D., Brito, I., Romero-Fernandez, W., Di Palma, M., Oflijan, J., Skieterska, K., Duchou, J., Van Craenenbroeck, K., Suárez-Boomgaard, D., Rivera, A., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058570 · Cited by 134
“The impact of the D2 receptor on information handling is also demonstrated by the fact that it is the major target for antipsychotic drugs [83].”
BackgroundSelf-citationFuxe, K., Marcellino, D., Borroto-Escuela, D. O., Frankowska, M., Ferraro, L., Guidolin, D., Ciruela, F., & Agnati, L. F. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2010.506191 · Cited by 74
“Novel strategies for drug treatment have been introduced based on targeting the heterodimers and receptor mosaics and the use of combined treatments in view of the likely existence of disease and tissue specific heteromers (40,56,57,62,63).”
BackgroundSelf-citationGPCR Oligomerization: Contribution to Receptor Biogenesis
Van Craenenbroeck, K. (2012) · Subcellular Biochemistry · doi:10.1007/978-94-007-4765-4_3 · Cited by 18
Metadata
- Authors
- Fuxe, K., Marcellino, D., Woods, A. S., Giuseppina, L., Antonelli, T., Ferraro, L., Tanganelli, S., & Agnati, L. F.
- Venue
- Journal of Neural Transmission
- Published
- 2009-01-21
- Volume
- 116
- Issue
- 8
- Pages
- 923-939
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2082000217
- Cited by
- 42
- References
- 22
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.